Kali Chrysovergis
- Molecular Biology
- Rheumatology top 5%
- Cancer Research top 10%
- Physiology
- Oncology
- Co-authors
- Susan S. YamadaKenn HolmbeckHenning Birkedal‐HansenPaolo BiancoThomas E. ElingXingya WangJustin KosakA. Robin Poole
- Topics
- GDF15 and Related Biomarkers (4 papers)Protease and Inhibitor Mechanisms (3 papers)Bone and Dental Protein Studies (2 papers)
- Cited by
- RheumatologyCancer ResearchAging
- Partner nations
- United StatesCanadaChina
In The Last Decade
Kali Chrysovergis
8 papers receiving 546 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 244
- Rheumatology 196
- Cancer Research 175
- Physiology 125
- Oncology 119
Countries citing papers authored by Kali Chrysovergis
This map shows the geographic impact of Kali Chrysovergis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kali Chrysovergis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kali Chrysovergis more than expected).
Fields of papers citing papers by Kali Chrysovergis
This network shows the impact of papers produced by Kali Chrysovergis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kali Chrysovergis. The network helps show where Kali Chrysovergis may publish in the future.
Co-authorship network of co-authors of Kali Chrysovergis
This figure shows the co-authorship network connecting the top 25 collaborators of Kali Chrysovergis. A scholar is included among the top collaborators of Kali Chrysovergis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kali Chrysovergis. Kali Chrysovergis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 94 | |
| 2 | 41 | |
| 3 | 16 | |
| 4 | 27 | |
| 5 | 16 | |
| 6 | 176 | |
| 7 | 111 | |
| 8 | 69 |
About Kali Chrysovergis
Kali Chrysovergis is a scholar working on Rheumatology, Toxicology and Cancer Research, having authored 8 papers that have together received 550 indexed citations. Recurring topics across this work include GDF15 and Related Biomarkers (4 papers), Protease and Inhibitor Mechanisms (3 papers) and Bone and Dental Protein Studies (2 papers). The work is most often cited by research in Rheumatology (196 citations), Cancer Research (175 citations) and Aging (14 citations). Kali Chrysovergis has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Susan S. Yamada, Kenn Holmbeck, Henning Birkedal‐Hansen, Paolo Bianco, Thomas E. Eling, Xingya Wang, Justin Kosak, A. Robin Poole, William Ka Kei Wu and R. Clark Billinghurst. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Journal of Cell Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.